Riskpilot← Back to searchSign inGet full accessMaBe i Sverige AB
ABActiveOrg 5567458293Stackvägen 11Medical specialists activities · NACE 8622Est. 20072 employees
Revenue 2025
SEK 2,2M
+3% vs 2024
EBITDA margin
23.7%
+195% vs 2024
Equity ratio
88.8%
Financial strength
Net profit 2025
SEK 421K
+97% vs 2024
| Revenue | SEK 2,2M | +3% |
| EBITDA | SEK 525K | +195% |
| Net profit | SEK 421K | +97% |
| Total assets | SEK 2,7M | -6% |
| Equity | SEK 2,4M | -10% |
| Employees | 2 | — |
Legal name
MaBe i Sverige AB
Org number
5567458293
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
7 december 2007
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet inom läkartjänster, föreläsningar och övrigt rörande hudsjukdomar. Bolaget ska även bedriva förvaltning av värdepapper, samt därmed förenlig verksamhet.
Address
Stackvägen 11
Phone
+46706315412
Email
644berg@telia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 493 | 1 965 | 1 983 | 2 148 | 2 211 |
| Staff expenses | — | −1 501 | −1 630 | −1 695 | −1 406 |
| EBITDA | −243 | 250 | 192 | 178 | 525 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −243 | 250 | 192 | 178 | 525 |
| Net financials | −246 | 49 | 162 | 92 | 27 |
| Profit before tax | 3 | 299 | 354 | 270 | 551 |
| Tax | −0 | −58 | −74 | −56 | −131 |
| Net profit | 3 | 241 | 280 | 214 | 421 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 989 | 3 623 | 3 263 | 2 831 | 2 655 |
| Equity | 3 869 | 3 424 | 3 076 | 2 626 | 2 357 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 120 | 199 | 186 | 205 | 298 |
| Total debt | 120 | 199 | 186 | 205 | 298 |
EBITDA margin
23.7%
This company
15.8%
Market median
+50% vs market
20212025
Equity ratio
88.8%
This company
38.2%
Market median
+132% vs market
20212025
Return on equity
17.9%
This company
18.4%
Market median
+3% vs market
20212025
Net profit margin
19.0%
This company
8.1%
Market median
+135% vs market
20212025
Asset turnover
0.83×
This company
1.12×
Market median
+26% vs market
20212025
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MaBe i Sverige AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats Gunnar Berg | Board of Directors | 0 companies |
| Ing-Marie Berg | Deputy Board Member | 0 companies |